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Purpose: To compare the effects on exercise capacity and health related quality of
life (HRQoL) of two exercise programmes; one programme including endurance
training and one including only resistance training and callisthenics. A second
purpose was to find out whether the severity of chronic obstructive pulmonary
disease (COPD) affected the training response and whether the interventions had a
long-term effect.
Methods: Sixty-three patients were stratified according to severity of COPD and
randomised to two training groups. Group A had a mixed programme including
endurance training. Group B had resistance training and callisthenics. All trained
twice weekly for 8 weeks. A symptom-limited ergometer test, 12-min walking test,
dynamic spirometry, blood gas analysis at rest and HRQoL were measured before and
after the training period. Follow-up tests were conducted at 6 and 12 months after
training.
Results: Forty-two patients fulfilled the trial. In group A (n ¼ 20) peak exercise
capacity increased by 7W (Po0:001) and 12-min walking distance (12MWD) by 50m
(Po0:01), whereas group B (n ¼ 22) did not change in any of these variables. HRQoL
did not change significantly in either group. Training response was similar in patients
with moderate and severe disease. One year post-training 12MWD had returned to
pre-training level in group A, and below pre-training level in group B (Po0:05).
Conclusions: Exercise capacity in patients with severe and moderate COPD
improved by intensive endurance training, two sessions a week for 8 weeks. TheElsevier Ltd. All rights reserved.
6110230; fax: +46 18 6110228.
medsci.uu.se (R. Harpa Arnardo´ttir).
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Two different training programmes for patients with COPD. 131improvement was however small and HRQoL did not improve. Severity of illness did
not affect response to training. The results indicated that the effects of a short
endurance training intervention slowed down decline in baseline functional exercise
capacity for 1 year.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Pulmonary rehabilitation is now a generally ac-
cepted approach for patients with moderate to
severe chronic obstructive pulmonary disease
(COPD).1 Exercise training is an important part of
the rehabilitation programme2 but it is still unclear
how the training should be performed in terms of
the mode of training, intensity, frequency and
duration. The American College of Sports Medicine
(ACSM) recommends that a programme for healthy,
elderly people should include endurance training,
strength training and flexibility training.3 For
patients with COPD endurance training has yielded
the best documented results so far, and high
intensity training has been found to be more
effective than low intensity training.4,5 Peripheral
muscle weakness is considered to contribute to
exercise limitation in COPD and resistance training
has been shown to increase strength in patients
with COPD6–10. It is however still unclear whether a
resistance programme affects exercise capacity or
not6,7,9 or if endurance training is an indispensable
part of pulmonary rehabilitation.
In some studies extensive and expensive treat-
ment models including many sessions a week have
been used and have resulted in impressive im-
provements.4,11 These programmes are not always
possible to conduct within existing resources in
clinical practice. Programmes with less frequent
sessions are less costly, but not necessarily efficient
to the patients.12 Some authors have found
exercise twice a week efficient13,14 while others
have not.12 Most studies have been done with
exercise sessions three times a week or
more.2,6,9,10,15 It has been recommended that
endurance training for patients with COPD should,
as a minimum, consist of three sessions a week for
at least 6–8 weeks.16 At present, however, many
clinics in Sweden offer their patients training only
twice a week during out-patient rehabilitation.
Physical training alone has been shown to affect
health-related quality of life (HRQoL),7,10,17 find-
ings that have not been confirmed by others.18 Both
moderately and severely ill patients may benefit
from training but it is unclear whether certain
exercise programmes are equally beneficial to both
groups.4,5,15In healthy subjects the effects of training usually
are lost after 10–32 weeks of detraining.3 Studies
on long-term effects of exercise in COPD patients
have found persistency of some effects for a year or
longer during follow-up, but most of these studies
include some form of maintenance train-
ing.18–20,21–23 Whether there can be any long-term
effects of a short training intervention for moder-
ate to severely ill COPD patients, without offering a
maintenance programme, is unclear.
The aim of the present study was to compare the
effects of an exercise programme including endur-
ance training with a programme of resistance
training and callisthenics alone, when exercising
twice a week for 8 weeks and to investigate
whether severity of the disease affected the
training response. Furthermore, the aim was to
find out whether the intervention had a long-term
effect.Methods
Subjects
Seventy-one COPD patients (36 women) were
consecutively invited to take part in the study
when being referred for training to the Physiother-
apy Unit of the Pulmonary Section at the Central
Hospital in Va¨stera˚s, Sweden. All were smokers or
ex-smokers. The study was approved by the Medical
Ethics Committee of Uppsala University and all
subjects gave informed consent.
Only patients with the diagnosis of COPD, an
FEV1/FVC-ratio o0.7 after bronchodilatation, a
smoking history of more than 10 years and forced
expiratory volume in 1 s (FEV1) o60% of predicted
value were included. Exclusion criteria were other
diseases that could interfere with training (e.g.
ischemic cardiac disease, musculo-skeletal pro-
blems) and an increase of FEV1420% following
inhalation of a bronchodilator.Study design (Fig. 1)
After dynamic spirometry and arterial blood gas
analysis each subject underwent a symptom-lim-
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monitoring. Functional exercise capacity was mea-
sured by a 12-min walking test in a level corridor.24
HRQoL was measured by the St. George’s Respira-
tory Questionnaire (SGRQ)25 and anxiety and
depression by the Hospital Anxiety and Depression
Scale (HAD).26 At the pre-trial tests eight sub-
jects were excluded from the study because
of cardiac problems or a bronchodilator response
(FEV1) of more than 20%. The remaining 63 subjects
were divided into those with severe disease
(FEV1o40% of predicted value), and moderate
disease (FEV1 40–59% of predicted value).
27
After the stratification, the subjects with moderate
and severe disease, respectively, were blindly
randomised (in blocks of four) to an exercise
programme including endurance training, resis-
tance training and callisthenics (group A) or a
programme of only resistance-training and cal-
listhenics (group B). All subjects trained for eight
weeks, twice a week and each session lasted for
about 75min in groups of three to six subjects.
After 8 weeks of training, the pre-trial tests were
repeated. A criterion for fulfilling the training was
participation of at least 12 of the 16 sessions. Pre-
and post-training tests were performed less than 2
weeks before and after the exercise period,
respectively.
Follow-up measurements were made at 6 and 12
months post-training. Measurements during follow-71 patients
Severely ill: 42
Stra
Group A: 
21
Group B: 
21
Ran
n=13 n=14
n=10 n=11
n=10 n= 9
63 pati
Completed 
training
6 months
12 months
Figure 1 Flow-chart showing inclusion, stratification, raup were dynamic spirometry, blood-gas analysis at
rest, 12-min walking test and HRQoL.Testing
FEV1 and vital capacity (VC) (P K Morgan Ltd.,
Rainham, England) were stated as the best of three
acceptable manoeuvres in accordance with the
American Thoracic Society guidelines for standar-
disation of spirometry 1987.28
For arterial blood gas analysis at rest (Bergman
and Beving, Copenhagen, Denmark) a blood sample
was taken from arteria radialis and PaO2, PaCO2 and
SaO2 were analysed.
The peak exercise capacity in watt (peak W) was
determined by a symptom-limited incremental
cycle ergometer test (RE 830, Rodby Elektronik
AB, Enho¨rna, Sweden) with continuous ECG regis-
tration (Megacart, Siemens Elema AB, Solna,
Sweden). After 1min of pedaling at a work rate of
10W, the work rate was increased by 10W per
minute until exhaustion.
Twelve-minute walking test was performed in a
34m level corridor.24 Two tests were done for
practice, and a third test served as baseline.29–31
After training and during follow-up only one test
was performed each time. To prevent bias from the
testing supervisor, no encouragement was given,
except telling the subjects the time with standard gave informed consent
8 excluded due to 
reversibility or 
cardiac problems
Moderately ill: 21
tification
Group A: 
10
Group B: 
11
domisation
n=7 n=8
n=7n=7
n=7 n= 6
ents included
ndomisation and participation throughout the study.
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oxygen saturation (SpO2%) was registered by a non-
invasive pulsoxymeter (Nellcor Incorp., Hayward,
USA). Peak expiratory flow (PEF), heart rate, SpO2%
and breathing frequency were measured and
subjects rated their exertion and breathlessness
on the Borg scales RPE and CR-1032,33 before
starting, after 6min, at the end of the walk and
5min after walking, respectively.
HRQoL was assessed by SGRQ.25 The question-
naire has three domains:
’ ’
Symptoms’’,
’ ’
Activity’’
and
’ ’
Impact’’ and, in addition, a
’ ’
Total’’ score is
calculated. The highest (worst) possible score for
every component is 100. The HAD26 was used to
measure anxiety and depression. The highest
(worst) score possible for anxiety and depression,
respectively, is 21. Both questionnaires are self-
administered.Training
The endurance training consisted of interval train-
ing on an ergometer cycle (Monark, Varberg,
Sweden). After 6min warming up at a low work
load (20–30% of peak W), ten 3-min intervals with
reciprocal high/low work loads followed (total
ergometer time 36min). The lower work rate was
30–50% and the higher work rate was at least 80% of
baseline peak W. After every interval, perception
of exertion and breathlessness were assessed using
the Borg-scales RPE and CR-10, respectively. After
the higher work load intervals, target ratings were
X15(RPE) and/orX5 (CR-10). The subjects’ ratings
and the therapist’s observations were used to
choose the appropriate level of work load for the
next interval, according to the above limits. After
cycling the subjects stretched the muscles in thighs
and legs. Once a week, the endurance training was
followed by resistance training (30min), and once a
week instead of resistance training followed by
15min of callisthenics and 15min of relaxation.
During resistance training, the subjects exercised
in their own rhythm for about 30min, taking as long
breaks to recover between different moments as
they needed. The David Back Clinic apparatus
(David Fitness and Medical, Helsinki, Finland) and
a usual treatment bench were used. The pro-
gramme consisted of exercises for the arms and
shoulders (David 400, 420 and 610), legs (David 200
and 300), and abdominal muscles (sit-ups). Resis-
tance was initially chosen so that the subjects were
able to perform 15 lifts (approximately 65% of one
repetition maximum). When 20 lifts were accom-
plished, resistance was increased. Sit-ups weredone on a bench in the supine position with knees
bended (soles on mattress).
The callisthenics were done in the sitting position
during approximately 15min. The main emphasis
was on unsupported arm exercises (shoulder flexion
and circumduction, scapular elevation and depres-
sion) mobility exercises for thorax and neck
(flexion, extension, rotation and lateral flexion;
including stretching), and breathing exercises. The
callisthenics were followed by 15min relaxation ad
modum Jacobson.34 All subjects were taught
pursed-lip-breathing technique to use during ex-
ercise.
In conclusion, endurance training was performed
twice a week in group A, resistance training and
callisthenics were performed once a week in group
A and twice a week in group B.
All subjects were encouraged to be physically
active at home during the 8 weeks, but no special
home-training programmes or diaries were used.
Subjects with hypoxia (SpO2o90%) during exercise
were administered supplementary oxygen by a
nasal cannula while exercising, just enough to keep
the saturation at or above 90%. SpO2 was monitored
with non-invasive pulseoximetry during exercise.
Statistical analysis
Analysis of variance (ANOVA), the Student’s t-test
for paired observations (parametric variables) and
Wilcoxon’s signed ranks test (SGRQ and HAD) were
used to compare the results before and after
training in each group. Comparisons of changes
between groups were made by analyses of covar-
iance, Student’s t-test for unpaired observations
(parametric) and Mann–Whitney test (SGRQ and
HAD). Spearman’s rank correlation was used to
estimate the association between changes in
physical function, quality of life and lung function
during training and at follow-up. To calculate
changes over time during the follow-up Friedman’s
test and Wilcoxon signed rank tests were used for
related/paired observations. A P-value o0.05 was
considered statistically significant. Results are
referred to in the text as mean7standard error of
mean. For significant difference between the
groups, if one group increased their 12MWD by
35% and the other by 5%, a group size of 21 patients
would yield a power of 80% if a ¼ 0:05.Results
Twenty subjects in group A and 22 in group B
completed the trial. There were no baseline
ARTICLE IN PRESS
R. Harpa Arnardo´ttir et al.134differences between the groups (Tables 1 and 2).
Twenty-one subjects (11 in group A) did not
complete the training intervention, 10 due to
exacerbations, eight due to lack of motivation or
psychological problems, and three due to back
pain. The drop-outs had lower PaO2 (8.8 kPa) and a
shorter 12MWD (700m) than those who completed
the trial (9.6 kPa and 831m, respectively, Po0:05).
Otherwise no differences were found between
drop-outs and other participants. During the 12
month follow-up, 10 subjects dropped out (three in
group A) (Fig. 1). Three subjects died, one movedTable 2 Exercise capacity and health related quality of
Group A, n ¼ 20
Baseline 8 we
12MWD (m) 854742 903
RPE at rest 7.270.4 6.3
CR-10 at rest 1.070.3 0.3
HAD depression 4.870.6 4.3
HAD anxiety 6.470.7 5.8
SGRQ symptom 54.774.5 49.9
SGRQ activity 63.073.7 63.7
SGRQ impact 38.473.9 34.2
SGRQ total 48.573.4 46.9
Mean7standard error of mean. 12MWD: walking distance in 12m
Borg scale for dyspnoea; HAD: hospital anxiety and depression sc
Significant difference from baseline Po0:05.
ySignificant difference between groups Po0:05.
Table 1 Characteristics of the patients who
completed the training programme, n ¼ 42
Group A,
n ¼ 20
Group B,
n ¼ 22
Gender (F/M) 10/10 11/11
Age (years) 6572 6872
BMI (kg/m2) 23.070.9 22,870.8
Pack-years 2973 3074
VC (l) 2.770.1 2.670.1
VC (% predicted) 7873 7673
FEV1 (l) 1.070.2 1.070.2
FEV1 (%predicted) 3773 3872
PaO2 (kPa) 9.570.3 9.870.3
PaCO2 (kPa) 5.670.2 5.370,1
SaO2 (%) 93.870.5 94.270.5
Mean7standard error of mean. BMI: body mass index; VC:
vital capacity; FEV1: forced expiratory volume in 1 s;
PaO2: arterial oxygen tension; PaCO2: arterial carbon
dioxide tension; SaO2 %: oxygen saturation of arterial
blood.from the area and six subjects got other serious
diseases.
In group A, peak exercise capacity improved by
772W (11%) (Po0:001) (Fig. 2), and 12MWD
increased by 50m772m (6%) (Po0:01) (Table 2).
Group B did not improve significantly in any of
these variables (Fig. 2, Table 2). The difference in
peak watt (DW) differed between the groups
(Po0:05), whereas the difference of improvement
of 12MWD (D12MWD) did not reach statistical
significance (P ¼ 0:07) between groups. After the
8 weeks of training, the ratings of perceived
exertion and the ratings of dyspnoea at rest were
significantly different between the groups (Po0:01
and o0:05, respectively) (Table 2). The SGRQ and
HAD scores did not change significantly by training
in any of the groups, (Table 2), although a tendency
towards lower scores (improvement) emerged in
group B for the SGRQ item
’ ’
activity’’ (3.674.5
points, P ¼ 0:07) and total score (2.073.2 points,
P ¼ 0:08). There was no correlation between the
change in peak watt or 12MWD and the changes in
SGRQ.
Lung function (spirometry) and blood gases were
not influenced by the training period in neither
group.
Twenty-seven subjects (13 in group A) had severe
and 15 (7 in group A) moderate disease (Fig. 1).
Apart from spirometry they differed significantly
only in peak watt at baseline (56W73 vs. 7278,
Po0:05). There was no difference in the effect of
training between those with severe and moderate
disease (Fig. 3).
At 6 months the 12MWD did not differ signifi-
cantly from baseline level in either group (Table 3).life at baseline and after 8 weeks of training.
Group B, n ¼ 22
eks Baseline 8 weeks
7 46 811750 819752
7 0.1 8.370.6 8.2y70.5
7 0.1 1.570.4 1.0y7 0.5
70.6 4.770.6 4.570.7
70.8 6.370.8 5.570.8
74.8 51.174.1 50.073.9
73.9 68.672.8 65.072.7
73.9 39.073.0 37.573.7
73.5 49.972.7 47.972.8
in; RPE: Borg scale for ratings of perceived exertion; CR-10:
ale; SGRQ: St. George0s Respiratory Questionnaire.
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Group B
n = 22
Baseline After 8 weeks
TIME
45
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Figure 2 Peak exercise capacity in watt (peak W) before and after 8 weeks of training in group A and B. Mean and 95%
conficence interval. ***Po0:001 difference in group A; yPo0:05 for difference between the groups in pre–post training
peak W (DW).
Baseline After 8 weeks
TIME
40
60
80
100
pe
ak
 W
 (w
att
)
Moderate
n= 7
Severe
n = 13
Figure 3 The effect of training on peak exercise capacity in watts (peak W), in group A, for subjects with severe and
moderate COPD. Mean and 95% confidence intervals.
Two different training programmes for patients with COPD. 135There was a further decline in 12MWD from 6 to 12
months in group B (Po0:05), but not in group A
(P ¼ 0:09). At 12 months post-training the 12MWD
was not significantly different from baseline in
group A (P ¼ 0:19), whereas it had declined in
group B (79m724m, Po0:05) (Fig. 4), but the
difference between the groups was not significant.The difference between groups in CR-10 scores for
dyspnoea at rest was still evident 6 months post-
training (Po0:05) but not after 12 months, whereas
the RPE-difference at rest persisted throughout the
follow-up (Po0:05) (Table 3).
Lung function showed small, but significant
decline in VC at 12 months post-training in group
ARTICLE IN PRESS
Table 3 Twelve-minute walking distance, health related quality of life and lung function at 6 and 12 months
after training.
Group A Group B
6 months, n ¼ 17 12 months, n ¼ 17 6 months, n ¼ 18 12 months, n ¼ 15
12MWD (m) 862755 816756 795759 767773
RPE at rest 6.670.3 6.670.3 8.1y70.5 8.2y70.6
CR-10 at rest 0.370.1 0.670.2 1.0y70.3 1.170.3
HAD depression 4.470.7 4.370.8 4.370.7 4.170.7
HAD anxiety 5.770.9 5.970.9 5.470.7 6.271.1
SGRQ symptom 48.975.5 49.475.7 54.474.8 49.174.4
SGRQ activity 65.673.7 66.273.8 64.673.7 69.474.0
SGRQ impact 36.574.2 40.574.3 36.273.5 37.872.6
SGRQ total 46.974.0 47.273.0 47.875.0 48.573.0
VC (l) 2.770.2 2.57 0.2 2.770.2 2.970.2
VC (%pred.) 7973 7474 8074 8574
FEV1 (l) 1.070.1 0.970.1 1.070.1 1.070.1
FEV1 (%pred.) 3873 3573 3872 4079
Mean7standard error of mean. 12MWD: walking distance in 12min; RPE: Borg scale for ratings of perceived exertion; CR-10:
Borg scale for dyspnoea; HAD: hospital anxiety and depression scale; SGRQ: St. George0s Respiratory Questionnaire.
Significant difference from baseline Po0:05.
ySignificant difference between groups Po0:05.
Baseline After 8 weeks 6 months
post training
12 months
post training
TIME
550
600
650
700
750
800
850
900
950
1000
1050
1100
12
M
W
D
 (m
ete
rs) Group An = 17
Group B
n = 15
*
*
Figure 4 The 12-min walking distance (m), for the 32 subjects that were followed-up for 12 months after training.
Means and 95% confidence intervals. *Significant difference from baseline Po0:05.
R. Harpa Arnardo´ttir et al.136A (0.2 L, Po0:05) compared to baseline (Tables 1
and 3). There was no correlation between changes
in 12MWD and lung function during the study. There
were no changes in PaO2, PaCO2 or SaO2 during the
time of the study (14 months).At 12 months post-training there was a tendency
towards lower scores in SGRQ symptoms in group A
compared to baseline (7.574.3, P ¼ 0:07). No
other changes in SGRQ or HAD emerged during
follow-up in either group.
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training groups and there was no difference in
response to training between the genders.Discussion
The present study showed that two sessions a week
for 8 weeks of a combined exercise programme,
including endurance training, increased exercise
capacity in patients with severe or moderate COPD.
It also showed that the training response did not
differ between subjects with severe and moderate
disease. There was, however, only a minor im-
provement and no effect could be demonstrated in
quality of life assessments. In the present model,
resistance training and callisthenics alone was
neither sufficient to influence exercise capacity
nor HRQoL. The small increase in functional
exericse capacity by the endurance training pro-
gramme was lost 6 months post-training, but
decline from baseline was prevented for at least
12 months post-training. Significant difference
between groups after the intervention was found
only in increase in peak W and in dyspnoea and
perceived exertion at rest. As the response to
training was smaller than we predicted, the power
was probably too low to detect other differences
between the groups.
Our results differ somewhat from the findings of
Ringbaek et al.,12 who did not find any improve-
ment in exercise capacity when exercising twice a
week for 8 weeks. Their target intensity of training
was somewhat lower and the training sessions
shorter than in the current study which may explain
the different outcome in the two studies. Five
studies of supervised exercise three times a week
for 8–12 weeks comparing the effects of strength
training with controls, endurance training with
resistance training or a combination of both
supported that endurance training increased exer-
icse capacity, whereas the effect of resistance
training on exercise capacity varied.6–10 Some
authors found that resistance training could in-
crease endurance but did not add anything to peak
exercise capacity or 6min walking distance6,9 while
others found that even resistance training could
increase peak exercise capacity.7 According to this,
an endurance test might be the most sensitive test
and therefore preferred when testing changes in
physical performance. The resistance training was
more intensive in the above quoted studies than in
the current one and it could be argued that the
intensity of the resistance training in our study was
too low and/or the sessions too few to influencepeak W or 12MWD.7 In the present study, the
intensity of endurance training was similar to
previous studies but was performed only twice a
week instead of three times a week.7,9,10 Thus, the
relatively small effects of endurance training in the
present study might be because of a lower total
dosis of training.
Two recent meta-analyses showed that multi-
disciplinary pulmonary rehabilitation improves
physical function and HRQoL.2,35 In some of the
papers included in the meta-analyses HRQoL
improvement has been found after training
intervention alone.7,10 In the present study,
physical function, but not HRQoL, depression or
anxiety scores were improved in group A. In the
meta-analysis by Lacasse et al., based on 15
studies, the effects on peak W (weighted
mean difference) was 5.5W (95% CI 0.49–10.23)
and in most of these trials HRQoL improved.2 The
lack of effect on HRQoL in the present study,
which has included a similar number of patients as
most of the trials included in the meta-analysis,2,35
indicates that the relationship between peak
exercise capacity and HRQoL is not strong. This is
in line with previous findings.17,36,37 The increase in
12MWD in group A, although statistically
significant, was small, 50m. In the meta-analysis
by Lacasse et al. a weighted mean difference of
49m (95% CI 26–72m) was found in 6-min
walking distance.2 As a test of a longer duration
(12min) would need a larger absolute improve-
ment for a similar effect, the outcome of the
present study is inferior to what was described in
the meta-analysis. HRQoL has been shown to
correlate better with walking distance than with
peak W.38 The small difference in walking distance
in our study might explain the lack of effect on
HRQoL. As the intensity of the endurance training
in our study was similar to other studies7–10 the
small effect on walking distance probably indicates
that two sessions a week for 8 weeks was a
suboptimal dosis of training. Another possible
explanation to lack of effect in HRQoL is that the
groups in the current study were small and that the
study was not powered to study HRQoL as a primary
outcome.
Another important difference between our and
previous trials is that we have used SGRQ25 while in
all the above studies the Chronic Respiratory
Disease Questionnaire (CRDQ)39 was used to eval-
uate HRQoL. These two instruments focus on
different aspects of HRQoL in COPD. There is also
a difference in the scoring scales which might
affect sensibility to smaller changes (seven-graded
in CRDQ, whereas most issues in SGRQ have two
grades).
ARTICLE IN PRESS
R. Harpa Arnardo´ttir et al.138In the present study, subjects with severe disease
responded to training similarly to subjects with
moderate disease. This finding is particularly
interesting in view of a recent meta-analysis in
which it was concluded that no effects of rehabi-
litation could be expected with a shorter interven-
tion than 6 months in subjects with severe COPD,
whereas subjects with moderate COPD responded
even to shorter programmes.35 Casaburi et al.15
found that subjects with severe COPD improved
their exercise capacity after a 6-weeks programme.
The intensity of the endurance training of their
study and the present one was higher than in
most of the studies on subjects with severe
disease included in the meta-analysis.15,35 The
different outcomes between studies analysing
effects on subjects with severe COPD per se, might
therefore be caused by a difference in the inter-
vention.
The small, but significant, increase in functional
exercise capacity (12MWD) in group A during the 8
weeks of training wore off with time during follow-
up. This was expected, as no maintenance pro-
gramme was offered. Some authors have found it a
challenge to maintain the effects of training, even
with some kind of maintenance programmes.20,22,40
COPD is a progressive disease, and in a recent
paper, patients with severe COPD were found to
decrease their 6MWD on average by 26m a year
during a 2-year study, non-survivors showing even a
larger decrease.41 They concluded that timed
walking distance (6MWD) progressively declines
over time in COPD. In the present study, at 12
months post-training (14 months from baseline)
group A had returned to baseline 12MWD, whereas
in group B 12MWD was significantly shorter than
baseline. Although 12MWD was not significantly
different between the groups during follow-up,
there was a significant difference between the
groups with regard to the RPE score at rest. This
strengthens the impression that the subjects in
group A preserved their physical function through-
out the study better than the subjects in group B.
This is an encouraging finding, indicating that a
temporary, minor increase in exercise capacity
during training may have effect in the long run by
holding back decline from baseline. The preserva-
tion of 12MWD in group A during the 14 months of
the study was possibly due to the short training
intervention. The groups were however small which
makes firm conclusions difficult.
Similar to some other studies12,21,42 the drop-
out was large in the present study. However, in
patients with severe COPD, hidden comorbidities
and frequent exacerbations are to be expected,
which makes it reasonable to assume that thecurrent study reflects
’ ’
real life’’ in pulmonary
rehabilitation.
We conclude that exercise capacity in patients
with severe to moderate COPD was significantly
improved by a 8 week training programme, two
sessions a week, only when intensive endurance
training was included in the programme. The
improvement in exercise capacity was small and
HRQoL was not improved. Severity of illness did not
affect exercise response. Exercise capacity was
back to baseline levels 6 months post-training. The
results indicated that the temporarily improvement
might have slowed down decline in baseline
functional exercise capacity for at least 1 year.Acknowledgements
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